Single-cell transcriptome profile during the antibody decline phase following inactivated COVID-19 vaccination
Frontiers in Cellular and Infection Microbiology · 2025
DOI: 10.3389/fcimb.2025.1715387 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Cellular and Infection Microbiology, 2025. Verfasst von Zhongyi Zhu und 8 weiteren Autor:innen. Beteiligte Einrichtung: College of Life Sciences, University of Chinese Academy of Sciences, Beijing, China. Hauptthemen laut MEDLINE: COVID-19, Antibodies, Viral, COVID-19 Vaccines, Transcriptome. Die Arbeit nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Introduction
Variability in antibody responses among individuals following vaccination is a common phenomenon. This study employs single-cell transcriptome sequencing to characterize the transcriptomic features underlying these variations during the antibody decline phase after inactivated COVID-19 vaccination.
Methods
Sixty-five healthy volunteers received two doses of BBIBP-CorV. Antibody levels were measured 109–140 days post-vaccination. From these, 15 samples representing low, median, and high antibody titers were selected for PBMC single-cell RNA sequencing.
Results
Re-analysis of antibody kinetics revealed that titers during the decline phase are most strongly associated with long-term persistence. Differentially expressed genes were enriched in immune pathways including lymphocyte activation, antigen presentation (MHC-I and MHC-II), and interferon signaling. Significant variation in HLA genes, particularly HLA-B, was observed across PBMC cell types. Cell-cell communication analysis further identified enhanced MHC-I signaling in high-titer groups, dominated by HLA-B interactions with CD8+ T cells.
Discussion
These findings reveal a state of balanced immune alertness during the decline phase, providing insights into the cellular and molecular determinants of long-term humoral immunity and informing future vaccine design.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Life Sciences, University of Chinese Academy of Sciences, Beijing, China.
- Beijing Genomics Institute (BGI) Huo-Yan Engineering Technology, Shenzhen, China.
- Beijing Genomics Institute (BGI) Research, Shenzhen, China.
- College of Traditional Chinese Medicine, Changchun University of Chinese Medicine, Changchun, China.
- Beijing Genomics Institute (BGI) Research, Hangzhou, China.
- Shenzhen Proof-of-Concept Center of Digital Cytopathology, Beijing Genomics Institute (BGI) Research, Shenzhen, China.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Zhu, Z., Huang, Y., Sun, J., Li, M., Chen, Y., Huang, F., Liu, C., Chen, W., & Ma, J. (2025). Single-cell transcriptome profile during the antibody decline phase following inactivated COVID-19 vaccination. Frontiers in Cellular and Infection Microbiology. https://doi.org/10.3389/fcimb.2025.1715387
Vancouver
Zhu Z, Huang Y, Sun J, Li M, Chen Y, Huang F, et al. Single-cell transcriptome profile during the antibody decline phase following inactivated COVID-19 vaccination. Frontiers in Cellular and Infection Microbiology. 2025. doi:10.3389/fcimb.2025.1715387
BibTeX
@article{Zhu2025,
author = {Zhu, Zhongyi and Huang, Yaling and Sun, Jiatong and Li, Meirong and Chen, Yong and Huang, Fubaoqian and Liu, Chuanyu and Chen, Weijun and Ma, Jinmin},
title = {Single-cell transcriptome profile during the antibody decline phase following inactivated COVID-19 vaccination},
journal = {Frontiers in Cellular and Infection Microbiology},
year = {2025},
doi = {10.3389/fcimb.2025.1715387}
}
EUVIMED